Immune response to COVID-19 Vaccination in people with Diabetes Mellitus - COVAC-DM study
Latest Information Update: 05 Dec 2023
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms COVAC-DM
- 05 Dec 2023 Status changed from recruiting to completed.
- 20 Oct 2021 New trial record